PTC Therapeutics, Inc. (PTCT)
69.76
-1.26
(-1.77%)
USD |
NASDAQ |
May 21, 16:00
71.15
+1.38
(+1.99%)
After-Hours: 19:59
PTC Therapeutics Research and Development Expense (TTM) : 447.15M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 896.74M |
| Keros Therapeutics, Inc. | 96.95M |
| Insmed, Inc. | 828.00M |
| Madrigal Pharmaceuticals, Inc. | 451.53M |
| Protagonist Therapeutics, Inc. | 170.14M |